|
1.
|
Nath U and Grant R: Neurological
paraneoplastic syndromes. J Clin Pathol. 50:975–980. 1997.
View Article : Google Scholar
|
|
2.
|
Bataller L and Dalmau J: Paraneoplastic
neurologic syndromes. Neurol Clin. 21:221–247. 2003. View Article : Google Scholar
|
|
3.
|
Darnell RB and Posner JB: Paraneoplastic
syndromes involving the nervous system. N Engl J Med.
349:1543–1554. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Tanaka Y, Suzuki N, Takao M, Ichikawa A,
Susumu N and Aoki D: Paraneoplastic cerebellar degeneration with
fallopian tube adenocarcinoma. Gynecol Oncol. 99:500–503. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Land R, Carter J, Houghton R, Atkinson K
and Dalrymple C: Gynaecology meets neurology: paraneoplastic
cerebellar degeneration. Aust N Z J Obstet Gynaecol. 45:79–81.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Brock S, Ellison D, Frankel J, Davis C and
Illidge T: Anti-Yo antibody-positive cerebellar degeneration
associated with endometrial carcinoma: case report and review of
the literature. Clin Oncol (R Coll Radiol). 13:476–479.
2001.PubMed/NCBI
|
|
7.
|
Peterson K, Rosenblum MK, Kotanides H and
Posner JB: Paraneoplastic cerebellar degeneration. I. A clinical
analysis of 55 anti-Yo antibodypositive patients. Neurology.
42:1931–1937. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
De Beukelaar JW and Sillevis Smitt PA:
Managing paraneo-plastic neurological disorders. Oncologist.
11:292–305. 2006.
|
|
9.
|
Ashour AA, Verschraegen CF, Kudelka AP and
Kavanagh JJ: Paraneoplastic syndromes of gynecologic neoplasms. J
Clin Oncol. 15:1272–1282. 1997.PubMed/NCBI
|
|
10.
|
Bolla L and Palmer RM: Paraneoplastic
cerebellar degeneration. Case report and literature review. Arch
Intern Med. 157:1258–1262. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Anderson NE, Rosenblum MK and Posner JB:
Paraneoplastic cerebellar degeneration: clinical-immunological
correlations. Ann Neurol. 24:559–567. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Verschuuren J, Chuang L, Rosenblum MK,
Lieberman F, Pryor A, Posner JB and Dalmau J: Inflammatory
infiltrates and complete absence of Purkinje cells in
anti-Yo-associated paraneoplastic cerebellar degeneration. Acta
Neuropathol. 91:519–525. 1996. View Article : Google Scholar
|
|
13.
|
Lennon VA: The case for a descriptive
generic nomenclature: clarification of immunostaining criteria for
PCA-1, ANNA-1, and ANNA-2 autoantibodies. Neurology. 44:2412–2415.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Greenlee JE and Brashear HR: Antibodies to
cerebellar Purkinje cells in patients with paraneoplastic
cerebellar degeneration and ovarian carcinoma. Ann Neurol.
14:609–613. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Furneaux HM, Rosenblum MK, Dalmau J, Wong
E, Woodruff P, Graus F and Posner JB: Selective expression of
Purkinje-cell antigens in tumor tissue from patients with
paraneoplastic cerebellar degeneration. N Engl J Med.
322:1844–1851. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Okano HJ, Park WY, Corradi JP and Darnell
RB: The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates
c-Myc function: implications for neuronal and tumor cell survival.
Genes Dev. 13:2087–2097. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
McKeon A and Pittock SJ: Paraneoplastic
encephalomyelopathies: pathology and mechanisms. Acta Neuropathol.
122:381–400. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Albert ML, Darnell JC, Bender A, Francisco
LM, Bhardwaj N and Darnell RB: Tumor-specific killer cells in
paraneoplastic cerebellar degeneration. Nat Med. 4:1321–1324. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Vedeler CA, Antoine JC, Giometto B, et al:
Management of paraneoplastic neurological syndromes: report of an
EFNS Task Force. Eur J Neurol. 13:682–690. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Levite R, Fishman A, Kesler A, Altaras M
and Gadoth N: Paraneoplastic cerebellar degeneration heralding
fallopian tube adenocarcinoma. Int J Gynecol Cancer. 11:169–171.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Rojas I, Graus F, Keime-Guibert F, Reñé R,
Delattre JY, Ramón JM, Dalmau J and Posner JB: Long-term clinical
outcome of paraneoplastic cerebellar degeneration and anti-Yo
antibodies. Neurology. 55:713–715. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Shams’ili S, Grefkens J, de Leeuw B, van
den Bent M, Hooijkaas H, van der Holt B, Vecht C and Sillevis Smitt
P: Paraneoplastic cerebellar degeneration associated with
antineuronal antibodies: analysis of 50 patients. Brain.
126:1409–1418. 2003.PubMed/NCBI
|
|
23.
|
Greenberg HS: Paraneoplastic cerebellar
degeneration. A clinical and CT study. J Neurooncol. 2:377–382.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Goldstein BH, Birk CL, Van Houten M, Veve
R, Brown JV, Rettenmaier MA and Micha JP: Ovarian cancer and late
onset paraneoplastic cerebellar degeneration. Arch Gynecol Obstet.
280:99–101. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Cao Y, Abbas J, Wu X, Dooley J and van
Amburg AL: Anti-Yo-positive paraneoplastic cerebellar degeneration
associated with ovarian carcinoma: case report and review of the
literature. Gynecol Oncol. 75:178–183. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Perlmutter E and Gregory PC:
Rehabilitation treatment options for a patient with paraneoplastic
cerebellar degeneration. Am J Phys Med Rehabil. 82:158–162. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Moll JW, Henzen-Logmans SC, Van der Meché
FG and Vecht CH: Early diagnosis and intravenous immune globulin
therapy in paraneoplastic cerebellar degeneration. J Neurol
Neurosurg Psychiatry. 56:1121993. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Counsell CE, McLeod M and Grant R:
Reversal of subacute paraneoplastic cerebellar syndrome with
intravenous immunoglobulin. Neurology. 44:1184–1185. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Blaes F, Strittmatter M, Merkelbach S,
Jost V, Klotz M, Schimrigk K and Hamann GF: Intravenous
immunoglobulins in the therapy of paraneoplastic neurological
disorders. J Neurol. 246:299–303. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Widdess-Walsh P, Tavee JO, Schuele S and
Stevens GH: Response to intravenous immunoglobulin in anti-Yo
associated paraneoplastic cerebellar degeneration: case report and
review of the literature. J Neurooncol. 63:187–190. 2003.
View Article : Google Scholar
|
|
31.
|
Thöne J, Hohaus A, Lamprecht S, Bickel A
and Erbguth F: Effective immunosuppressant therapy with
cyclophosphamide and corticosteroids in paraneoplastic cerebellar
degeneration. J Neurol Sci. 272:171–173. 2008.PubMed/NCBI
|
|
32.
|
Mowzoon N and Bradley WG: Successful
immunosuppressant therapy of severe progressive cerebellar
degeneration and sensory neuropathy: a case report. J Neurol Sci.
178:63–65. 2000. View Article : Google Scholar : PubMed/NCBI
|
